Research & Development

In 2023, the market for cell and gene therapy was worth USD 18.8 billion. In the years to come, the...

Cell and gene treatments are now one of the pharmaceutical industry’s fastest-growing segments, with more and more being investigated for...

Analytical as well as research laboratories happen to be at the heart of driving scientific breakthroughs in order to address...

Top-down treatment by way of infliximab Plus, which is an immunomodulator, goes on to substantially enhance the outcomes for patients...

The FDA has gone on to publish its final guidance on January 30, 2024, that goes on to offer consideration...

It is well to be noted that the positive results from the first global study for chimeric antigen receptor (CAR)-antologous...

The BRCA gene testing initiative looks to identify individuals who carry genetic faults associated with an elevated risk of specific...

It has been determined that fluoroquinolone antibiotics should only be prescribed in cases where no other antibiotics happen to be...

The advent of powerful new drugs in the case of obesity has gone on to reshape the pharma sector, thereby...

Biotech companies go on to face numerous challenges, particularly while in the clinical phase of drug development, in today's fast-paced...